Iovance Biotherapeutics Inc (NASDAQ:IOVA)

27.80
Delayed Data
As of Aug 14
 -0.86 / -3.00%
Today’s Change
17.67
Today|||52-Week Range
41.49
+0.43%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Operating ActivitiesNet Income / Starting Line-27.7M-52.9M-92.1M-123.6M
 
 
 
 
 
Depreciation999.0K978.0K952.0K956.0K
 
 
 
 
 
Total Other Cash Flow8.5M18.8M12.0M18.7M
 
 
 
 
 
Funds From Operations-18.1M-33.1M-79.1M-103.9M
 
 
 
 
 
Funds From/For Other Operating Expenses243.0K-418.0K-416.0K-2.7M
 
 
 
 
 
Net Cash Flow - Operating Activities-18.4M-32.7M-78.7M-101.2M
 
 
 
 
 
 
InvestingIncrease In Investments-160.6M-110.2M0.00-426.1M
 
 
 
 
Decrease In Investments70.6M120.7M59.7M41.0M
 
 
 
 
 
Capital Expenditures-1.1M-1.5M-1.0M-1.2M
 
 
 
 
 
Net Cash Flow Investing-91.2M8.9M58.7M-386.3M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction0.000.000.000.00--
Net Proceeds Stock Sale78.3M97.5M59.9M424.3M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.00642.0K1.3M0.00
 
 
 
Net Cash Flow - Financing78.3M96.9M58.7M424.3M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash----------
 
Net Change In Cash-31.3M73.1M38.7M-63.2M